Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
0.920
+0.078 (9.25%)
At close: Mar 28, 2024, 4:00 PM
0.930
+0.010 (1.09%)
After-hours: Mar 28, 2024, 7:59 PM EDT

Cidara Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Cash & Equivalents
32.7362.2742.9560.2774.5660.8185.3762.5622.80.19
Short-Term Investments
0000014.519.2544.9500
Cash & Cash Equivalents
32.7362.2742.9560.2774.5675.31104.62107.5122.80.19
Cash Growth
-47.44%44.99%-28.74%-19.17%-1.00%-28.01%-2.69%371.64%12222.16%-
Receivables
5.835.3611.180.0100.320000
Other Current Assets
6.534.073.075.542.572.040.780.70.220.01
Total Current Assets
45.0971.757.1965.8177.1377.67105.4108.2223.010.2
Property, Plant & Equipment
1.432.541.212.060.711.041.371.680.860
Other Long-Term Assets
1.071.082.021.11.270.320.190.070.470
Total Long-Term Assets
2.53.633.233.161.981.371.561.761.340
Total Assets
47.5975.3360.4268.9879.1179.04106.96109.9724.350.2
Accounts Payable
1.451.34.571.892.852.592.913.11.180.03
Deferred Revenue
35.1432.3325.019.8000000
Current Debt
1.323.747.9610.789.932.670000
Other Current Liabilities
-7.93-3.361.027.737.126.8362.882.040.08
Total Current Liabilities
29.9734.0238.5630.219.8912.098.915.973.210.12
Long-Term Debt
01.3200.9407.219.79001.48
Other Long-Term Liabilities
20.5318.4111.1500.0800.080.090.030
Total Long-Term Liabilities
20.5319.7411.150.940.087.219.870.090.031.48
Total Liabilities
50.553.7549.7131.1419.9719.2918.786.063.251.6
Total Debt
1.325.067.9611.739.939.879.79001.48
Debt Growth
-73.98%-36.44%-32.09%18.10%0.56%0.81%----
Retained Earnings
-406.97-377.17-334.7-259.83-218.74-149.39-93.66-45.5-13.3-1.41
Comprehensive Income
00000-0.01-0-0.0100
Shareholders' Equity
-2.921.5710.7237.8459.1459.7488.18103.91-11.45-1.4
Net Cash / Debt
31.4157.2134.9948.5464.6365.4494.83107.5122.8-1.3
Net Cash / Debt Growth
-45.09%63.52%-27.93%-24.90%-1.23%-30.99%-11.80%371.64%--
Net Cash Per Share
0.451.090.841.622.503.746.5410.8427.80-4.01
Working Capital
15.1237.6818.6335.6257.2465.5996.49102.2419.80.08
Book Value Per Share
-0.040.410.261.262.293.416.0910.47-13.96-4.32
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).